RLMD icon

Relmada Therapeutics

109 hedge funds and large institutions have $66.6M invested in Relmada Therapeutics in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 57 closing their positions.

Holders
109
Holders Change
-25
Holders Change %
-18.66%
% of All Funds
1.76%
Holding in Top 10
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
New
34
Increased
29
Reduced
34
Closed
57
Calls
$7.39M
Puts
$1.67M
Net Calls
+$5.72M
Net Calls Change
+$87.3M
Name Market Value Shares Shares
Change
Shares
Change %
Janus Henderson Group
151
Janus Henderson Group
United Kingdom
-5,937 Closed
SFO
152
Stokes Family Office
Louisiana
-5,935 Closed
NFGH
153
Nan Fung Group Holdings
Hong Kong
-5,642 Closed
ProShare Advisors
154
ProShare Advisors
Maryland
-5,537 Closed
AA
155
AlphaCentric Advisors
Puerto Rico
-5,500 Closed
Zurich Cantonal Bank
156
Zurich Cantonal Bank
Switzerland
-3,321 Closed
CL
157
CSS LLC
Illinois
-2,253 Closed
MLICM
158
Metropolitan Life Insurance Company (MetLife)
New York
-1,651 Closed
PI
159
PEAK6 Investments
Illinois
-962 Closed
Canada Life
160
Canada Life
Manitoba, Canada
-840 Closed
CUAMC
161
China Universal Asset Management Company
China
-282 Closed
S
162
SignatureFD
Georgia
-278 Closed
MPWT
163
MassMutual Private Wealth & Trust
Connecticut
-92 Closed
Daiwa Securities Group
164
Daiwa Securities Group
Japan
-83 Closed
QCG
165
Quadrant Capital Group
Ohio
-47 Closed
SM
166
SG3 Management
Puerto Rico
SCM
167
Silverarc Capital Management
Massachusetts
KCM
168
Kynam Capital Management
New Jersey
Rockefeller Capital Management
169
Rockefeller Capital Management
New York
$0 27
CFGS
170
Concourse Financial Group Securities
Alabama
FIA
171
FNY Investment Advisers
New York
Macquarie Group
172
Macquarie Group
Australia
Wolverine Trading
173
Wolverine Trading
Illinois
HT
174
HAP Trading
New York
KCM
175
Kingdon Capital Management
New York